论文部分内容阅读
目的:采用匹多莫德和孟鲁司特钠治疗儿童支气管哮喘的疗效和安全性。方法:选取支气管哮喘患儿随机分为对照组和观察组各40例,对照组采用孟鲁司特钠治疗,观察组加用匹多莫德治疗,观察两组支气管哮喘患儿的临床疗效和不良反应发生情况。结果:观察组的总有效率较对照组高(P<0.05);两组患儿治疗的不良反应发生率对比无统计学意义(P>0.05)。结论:匹多莫德和孟鲁司特钠联合用药用于治疗儿童支气管哮喘疗效较明显,安全性较高。
PURPOSE: To evaluate the efficacy and safety of pidotimod and montelukast sodium in children with bronchial asthma. Methods: Forty children with bronchial asthma were randomly divided into control group and observation group, 40 cases in each group. The control group was treated with montelukast sodium. The observation group was treated with Pidotimod to observe the clinical efficacy and clinical efficacy of bronchial asthma in both groups. Adverse reactions occurred. Results: The total effective rate in the observation group was higher than that in the control group (P <0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P> 0.05). Conclusion: The combination of pidotimod and montelukast sodium is more effective and safe for the treatment of children with bronchial asthma.